6533b855fe1ef96bd12b1495

RESEARCH PRODUCT

Smoking does not impact social and non-social cognition in patients with first episode psychosis.

Salvador SarróLeticia García-álvarezJulio ArbejManuel J. CuestaAna CalvoAna CalvoGisela MezquidaRoberto Rodriguez-jimenezInmaculada BaezaSusana Al-halabíCarla TorrentIsabel Morales-muñozAna M. Sánchez-torresJosefina Castro-fornielesM. Paz García-portillaAnabel Martínez-aránAna González-pintoDaniel BergéIñaki ZorrillaAnna ButjosaVicent BalanzáEduardo J. AguilarTeresa Sánchez-gutiérrezTeresa Sánchez-gutiérrezAuria AlbaceteAuria AlbaceteAuria AlbaceteA. AlonsoJulio BobesMireia RabelaRamon Landin-romeroAntonio LoboBibiana CabreraJudith UsallJ.m. López-ilundainAnna ManéIluminada CorripioGonzalo RiveroFernando ContrerasFernando ContrerasFernando ContrerasLucía Moreno-izcoMiguel GutiérrezP. LópezMiguel BernardoMara ParelladaVieta EduardJulio SanjuánJerónimo Saiz RuizLaura RoldanRafael SegarraElena De La SernaAngela IbáñezMiquel Bioque

subject

AdultMaleAdolescent03 medical and health sciencesExecutive FunctionYoung Adult0302 clinical medicineCognitionSocial cognitionFirst episode psychosismedicineTobacco SmokingHumansLongitudinal StudiesProspective StudiesChildSocial BehaviorBiological PsychiatryWorking memorybusiness.industryCognitionTobacco Use DisorderExecutive functionsmedicine.disease030227 psychiatryPsychiatry and Mental healthCross-Sectional StudiesMemory Short-TermPsychotic DisordersSchizophreniaFemalebusinessNeurocognitive030217 neurology & neurosurgerySocial cognitive theoryClinical psychology

description

Abstract Background Many studies having shown significant improvements in non-social and social cognitive performance in smoking FEP patients compared to non-smoking FEP patients. The findings are controversial. This study analyzed the effects of tobacco use on non-social and social cognitive function in a large group of FEP patients and a matched healthy control group. Methods A sample of 335 patients with FEP and 253 healthy controls was divided into four subgroups: control tobacco users (CTU), control non-tobacco users (CNTU), patient tobacco users (PTU) and patient non-tobacco users (PNTU). Demographic variables, tobacco use variables (presence or absence, frequency and duration of tobacco use), neurocognitive (non-social) performance and social cognition were assessed. Results Comparison of 4 subgroups in non-social cognitive function revealed significant differences after controlling for covariables in executive functions (F = 13.45; p ≤0.001) and working memory domains (F = 4.30; p = 0.005). CTU and CNTU subgroups scored higher in all the domains compared to the PTU and the PNTU subgroups respectively. Social cognitive function was also significantly different within the four subgroups, with control subgroups showing better social cognition than patient subgroups. Significant differences in the executive functions domain were observed when comparing PTU and CTU groups (F = 19.60; p ≤0.001). No significant differences were revealed in the comparison between the patient groups. Conclusions This large study suggests that tobacco use in FEP patients is not related to better non-social or social cognitive performance.

10.1016/j.schres.2018.03.025https://pubmed.ncbi.nlm.nih.gov/29606546